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Background: The cervical zygapophyseal joints may be a primary source of pain in up to 60% of individuals with
chronic whiplash associated disorders (WAD) and may be a contributing factor for peripheral and centrally
mediated pain (sensory hypersensitivity). Sensory hypersensitivity has been associated with a poor prognosis. The
purpose of the study was to determine if there is a change in measures indicative of sensory hypersensitivity in
patients with chronic WAD grade II following a medial branch block (MBB) procedure in the cervical spine.
Methods: Measures of sensory hypersensitivity were taken via quantitative sensory testing (QST) consisting of
pressure pain thresholds (PPT’s) and cold pain thresholds (CPT’s). In patients with chronic WAD (n = 18), the
measures were taken at three sites bilaterally, pre- and post- MBB. Reduced pain thresholds at remote sites have
been considered an indicator of central hypersensitivity. A healthy age and gender matched comparison group (n
= 18) was measured at baseline. An independent t-test was applied to determine if there were any significant
differences between the WAD and normative comparison groups at baseline with respect to cold pain and
pressure pain thresholds. A dependent t-test was used to determine whether there were any significant differences
between the pre and post intervention cold pain and pressure pain thresholds in the patients with chronic WAD.
Results: At baseline, PPT’s were decreased at all three sites in the WAD group (p < 0.001). Cold pain thresholds
were increased in the cervical spine in the WAD group (p < 0.001). Post-MBB, the WAD group showed significant
increases in PPT’s at all sites (p < 0.05), and significant decreases in CPT’s at the cervical spine (p < 0.001).
Conclusions: The patients with chronic WAD showed evidence of widespread sensory hypersensitivity to
mechanical and thermal stimuli. The WAD group revealed decreased sensory hypersensitivity following a decrease
in their primary source of pain stemming from the cervical zygapophyseal joints.
Background
Cervical spine pain and dysfunction resulting from a
motor vehicle collision (MVC) are common patient pro-
blems encountered by health care practitioners. Many
patients will significantly recover with respect to neck
pain and disability within the first six months to one
year [1,2]. Researchers have reported that 32% to 56% of
those that have sustained a MVC will continue to suffer
pain and disability beyond the six month period [3-5].
The cervical zygapophyseal joint has been implicated
a sas o u r c eo fp a i ni nt h o s ew i t hc h r o n i cW A D[ 6 , 7 ] .
Studies utilizing controlled, comparative anaesthetic
nerve block procedures have reported that the preva-
lence of cervical zygapophyseal joint pain in those with
chronic WAD ranged from 54% to 60% [6,7]. Biomecha-
nical and neurophysiological studies have provided evi-
dence in support of cervical zygapophyseal joint
involvement in MVC’s [8-29].
Research has indicated that the ongoing pain asso-
ciated with chronic WAD may be due to altered pain
processing as evidenced by sensory hypersensitivity at
distant sites involving uninjured tissues [30-34]. Central
nervous system hyperexcitability may provide an expla-
nation for the generalized sensory hypersensitivity seen * Correspondence: gmschnei@ucalgary.ca
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hypersensitivity is characterized by decreased pain
thresholds to mechanical, thermal, and electrical stimuli
[30,31,33,34,36,37]. The presence of sensory hypersensi-
tivity, in particular cold hyperalgesia, in whiplash
patients has been associated with a poor prognosis
[3,33]. The precise mechanisms underlying sensory
hypersensitivity are unclear, but peripheral, spinal, and
supraspinal mechanisms have been hypothesized [32,38].
Alterations in neuronal excitability in the spinal cord,
secondary to ongoing peripheral nociception, has been
hypothesized as a mechanism of central hyperexcitability
[39,40]. Contributing to central hyperexcitability is the
activation of N-methyl D-aspartate (NMDA) receptors,
and subsequent release of cyclooxygenase-2 (COX-2) in
the spinal cord, as well as the activation of glial cells
[39,41,42]. Clinical manifestations of central hyperexcit-
ability are represented by lowered pain thresholds in
areas distant from the site of tissue injury (secondary
hyperalgesia) and allodynia. Another contributing factor
to central hyperexcitability stems from higher brain cen-
ters and is represented by the imbalance in descending
facilitatory and inhibitory pathways [35].
Structural injury secondary to trauma may lead to an
inflammatory response characterized by the release of
inflammatory mediators such as substance P, prostaglan-
dins, and bradykinin [42,43]. As a result of this inflamma-
tory response, peripheral nociceptors may become
sensitized. With long periods of nociception, primary
hyperalgesia may be maintained as peripheral nerve fibers
such as A-fibers, assume C-fiber characteristics [44].
Recently, it has been shown that myofascial trigger points
in the upper fibers of the trapezius in subjects with
chronic WAD may act as peripheral modulators of sensory
hypersensitivity [45]. Measures indicative of mechanical
hyperalgesia, taken via pressure pain thresholds over
hypothesized injured and uninjured tissues, were increased
immediately following local anaesthetic injection of the
myofascial trigger points, suggesting an alteration in cen-
tral pain processing. Contrarily, results of another investi-
gation revealed that anaesthetic injection of painful and
tender points in the cervical musculature of chronic WAD
subjects did not affect measures indicative of sensory
hypersensitivity, leading these researchers to believe that
sensory hypersensitivity was not maintained by nociceptive
input from these tissues [30]. It is possible that peripher-
ally mediated pain stemming from the underlying cervical
zygapophyseal joints may be a source of ongoing nocicep-
tive input into the central nervous system, thus facilitating
sensory hypersensitivity.
The aim of this study was to minimize cervical spine
pain intensity in patients with chronic WAD and to
evaluate its immediate effect on measures indicative of
sensory hypersensitivity. We hypothesized that a
decrease in cervical spine pain intensity following diag-
nostic blockade of the cervical zygapophyseal joints
would result in a change in measures indicative of sen-
sory hypersensitivity, specifically, an increase in pressure




This exploratory study involved a pretest-posttest
design. A healthy age- and gender-matched normative
comparison group was measured at baseline.
Subjects and Setting
Eighteen volunteers (3 males, 15 females, mean age 45
years ± 8) with whiplash associated disorders grade II as
defined by the Quebec Task Force classification (neck
complaint and musculoskeletal sign(s) including
decreased range of motion and point tenderness) and 18
healthy age- and gender-matched volunteers (3 males,
15 females, mean age 45 years ± 8) participated in this
study [46]. Patients with chronic WAD aged 18-60
years, reporting neck pain for greater than 6 months,
who experienced at least an 80 percent decrease in
familiar neck pain intensity following an intra-articular
zygapophyseal joint block procedure were included in
t h es t u d y .F r o mJ u n e2 0 0 7t oF e b r u a r y2 0 0 8 ,t h e
patients with chronic WAD were recruited from a ter-
tiary spinal intervention center in Calgary, Alberta,
Canada where they were scheduled for diagnostic cervi-
cal zygapophyseal joint blockade. All patients with
chronic WAD underwent unilateral cervical medial
branch block (MBB) procedures below the C2 level (ie;
C3-7) for their predominant neck pain (not headache).
The patients with chronic WAD were excluded if they
reported a previous history of neck pain or headaches
that required treatment. They were also excluded if they
were pregnant, had central or peripheral neurological
dysfunction, peripheral vascular disease or coronary
artery disease. The normative comparison group was
recruited through print advertisements at several phy-
siotherapy clinics and medical offices in the surrounding
community. The comparison subjects were included if
they did not currently report spinal, elbow, knee pain or
headache, had not been involved in a MVC, and had
not undergone treatment for neck pain or headache in
the past 2 years.
Ethics approval was granted by the Centre for
Advancement of Health at the University of Calgary
(Calgary, Alberta, Canada) and the Institutional Review
Board at Andrews University (Berrien Springs, MI,
USA).
Instrumentation
A single item Numeric Pain Rating Scale (0-10) was
used to measure the patients’ cervical spine pain
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tive sensory testing (QST), consisting of PPT’sa n d
CPT’s, was performed on the WAD and normative com-
parison subjects. The CPT’s were measured using the
TSA II Neurosensory Analyzer (Medoc Advanced Medi-
cal Systems; Minneapolis, MN, USA). The PPT’sw e r e
measured by an electronic pressure algometer (Somedic
AB; Farsta, Sweden).
Baseline measures also included a self-report measure
of neck pain and disability via the Neck Disability Index
(NDI: 0-100) [47]. Demographic variables including gen-
der, age (years), duration of neck pain (months), and liti-
gation status (retained a lawyer) were also recorded.
Quantitative Sensory Tests
Cold Pain Threshold Test
Cold pain thresholds were measured by placing the
thermode on the skin over the articular pillars of the
cervical zygapophyseal joints that were anaesthetized
during the MBB procedure. The thermode size was 30
millimeters × 30 millimeters. The thermode temperature
was set to 32°C. The temperature decrease was standar-
dized at a rate of 1°C per second. The minimal tempera-
ture was set to zero degrees Celsius. To identify CPT’s,
the patients were asked to push a self-controlled switch
as soon as the cold sensation changed to one of pain.
Three tests were performed bilaterally at each site and
the mean values were recorded for use in the statistical
analyses.
Psychometric properties for cold pain threshold test-
ing are lacking in the literature. In a study in healthy
adults, investigators reported good intrarater reliability,
ICC’s ranging from 0.79 to 0.94, for a clinical test of
cold pain threshold [48].
In our study, cold pain threshold testing was only per-
formed at the cervical spine only in order to standardize
our testing protocol with other investigations involving
subjects with WAD [33,49].
Pressure Pain Threshold Test
Pressure pain thresholds were measured at the following
sites: the articular pillars of the cervical zygapophyseal
joints that were anaesthetized during the MBB proce-
dure, the peripheral nerve trunk of the median nerve
(identifiable in the cubital fossa medial to and immedi-
ately adjacent to the biceps tendon), and the tibialis
anterior (at a site halfway between the most superior
attachment to the tibia and its tendon in the upper one
third of the muscle belly). The patients were asked to
push a self-controlled switch as soon as the sensation of
pressure changed to one of pain. The probe size was 1
cm
2 and the rate of application was standardized to 40
kPa/sec. Three tests were performed at each site bilater-
ally and the mean values were recorded for use in the
statistical analyses. Ten seconds was allowed between
each test.
Pressure pain threshold testing has demonstrated good
to excellent intrarater and interrater reliability in
patients with chronic WAD, with ICC’sr a n g i n gf r o m
0.85 to 0.91 and 0.88 to 0.97 respectively [50].
The QST protocols utilized in this study were repli-
cated from previous studies in chronic whiplash patients
[33,36,49].
Diagnostic Cervical Zygapophyseal Joint Blockade
The patients with chronic WAD were referred to our
tertiary spinal care center for diagnostic cervical zygapo-
physeal joint blockade. This process involved two diag-
nostic zygapophyseal joint block procedures. Prior to
the study, the patients with chronic WAD underwent a
diagnostic intra-articular zygapophyseal joint block pro-
cedure. For this procedure, a 25-gauge spinal needle is
advanced, under flouroscopic guidance, into the target
zygapophyseal joint with the patient in the prone posi-
tion. A small amount of nonionic contrast (0.5 cc of
Omnipaque 300® Amerslan Health, Oakville, ON,
Canada) was utilized to confirm proper needle position.
Subsequently, an injection of 0.5 cc of preservative free
1% Bupivicaine (AstraZeneca, Mississauga, ON, Canada),
a local anaesthetic, and 0.5 cc of Celestone (Celestone
Soluspan®, Schering, Pointe-Claire, Quebec, Canada), a
corticosteroid, was made into the target zygapophyseal
joint.
The referral source, the general practitioner, phy-
siotherapist, and/or medical specialist determined the
spinal level and side of the zygapophyseal joint block
based on the patients’ clinical presentation. The inter-
ventional radiologist confirmed the appropriate target
zygapophyseal joint based on clinical examination find-
ings, including established pain diagrams [51,52]. During
the post-injection follow-up period, if the patients with
chronic WAD reported a decrease in familiar cervical
spine pain intensity of at least 80 percent and their pain
returned, they underwent a second diagnostic cervical
zygapophyseal joint block, the MBB.
The MBB involved the placement of a 25-gauge spinal
needle, under fluoroscopic guidance, onto the medial
branch of the dorsal ramus as it courses over the waist
of the articular pillar at each spinal level. An injection of
nonionic contrast material (0.5 cc of Omnipaque 300®
Amerslan Health, Oakville, ON, Canada) was made to
confirm the proper needle position. Subsequently, 0.5 cc
of 2% Lidocaine (AstraZeneca, Mississauga, ON,
Canada), a local anaesthetic without preservatives, was
injected onto the medial branch of the dorsal ramus.
The medial branch of the dorsal ramus provides the
sensory innervation to the zygapophyseal joint above
and below the target joint as well as the deep parame-
dian muscles [7,53]. Hence, both medial branches to the
target joint need to be anaesthetized in order to effec-
tively anaesthetize one zygapophyseal joint [54].
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advocated for the diagnosis of zygapophyseal joint pain
[53-55]. In our study, for the diagnosis of zygapophyseal
joint mediated pain, we initially performed an intra-
articular anaesthetic-corticosteroid facet joint injection
to the suspected painful joints. Following this procedure,
if the patient experienced at least 80% relief of familiar
pain intensity and their pain returned they underwent a
diagnostic MBB procedure. Clinically, this diagnostic
pathway is used prior to consideration for radiofre-
quency neurotomy. Although the scientific literature is
varied, there is some evidence to suggest that a subset
of patients with suspected cervical zygapophyseal joint
pain might experience a therapeutic benefit from an
intra-articular injection, with respect to a decrease in
pain intensity over a period of three months or greater
[56]. As our centre provides pain management services
to a large catchment area, we possess a four to six
month wait-list for interventional techniques including
diagnostic zygapophyseal joint procedures. Historically,
we utilized a triple-injection procedure for the diagnosis
of zygapophyseal joint pain consisting of an intra-articu-
lar zygapophyseal joint injection, followed by controlled,
comparative MBB procedures. Our unpublished data
revealed that it was nearly universal, in that patients
that responded positively to both an intra-articular zyga-
pophyseal joint injection and the first MBB, responded
positively to the second MBB. By eliminating the second
MBB, we were able to reduce patient wait-time by
approximately 15-20%.
Procedures
Following written consent, the patients with chronic
WAD reported their pre-MBB cervical spine pain inten-
sity via the NPRS. They also completed the NDI. The
whiplash and the comparison groups underwent the
QST procedures. The QST were performed in the fol-
lowing order: CPT testing followed by PPT testing. A
set order of testing was performed to control for the
effect that one test could have on the results of another
test [57]. Expected findings were not stated to avoid the
potential effect of expectancy bias on the test results
[57]. All tests were performed by one of the investiga-
tors (GS). The instructions provided to the subjects
were standardized. The test sites were measured in a
random fashion in order to minimize a learning effect.
The comparison group underwent QST testing at base-
line only to allow for a statistical comparison of differ-
ences in PPT’sa n dC P T ’s between the this group and
the patients with chronic WAD.
Within 30 minutes of the baseline QST protocol, the
patients with chronic WAD underwent their scheduled
MBB procedure. If the patient reported an 80 percent or
greater relief in cervical pain intensity (via the NPRS)
within one hour post-MBB, they underwent a final
round of QST [58]. As the MBB procedure involves a
needle puncture, total pain relief is not always a realistic
outcome secondary to procedural discomfort. If the
patients with chronic WAD did not report at least an 80
percent decrease in cervical spine pain intensity they did
not continue in the study.
Data Analysis
Descriptive and inferential statistics were applied to
describe the baseline characteristics of the WAD and
normative comparison groups. Sample means and stan-
dard deviations were applied to continuous data. Fre-
quency counts were used to summarize categorical data.
Reliability analyses, ICC (2,3), along with standard error
of measurement calculations were performed on the left
and right side mean PPT and CPT data at the three
sites on the WAD group pre-and-post-MBB and the
normative comparison group at baseline. If the absolute
agreement was acceptable, then the mean left and right
side data were averaged and a point estimate representa-
tive of each body region were used for further analyses.
An independent t-test was applied to determine if
there were any significant differences between the WAD
and normative comparison groups at baseline, and fol-
lowing the MBB, with respect to cold pain and pressure
pain thresholds. A dependent t-test was used to deter-
mine whether there were any significant differences
between the pre and post-MBB cold pain and pressure
pain thresholds in the patients with chronic WAD. The
statistical software used to analyze the data was STATA
10.1 (StataCorp, College Station, TX, USA). Significance
level was set at p < 0.05.
Sample Size
An a priori sample size analysis indicated the need for at
least 18 subjects in each group. For the sample size ana-
lysis, considering the requirements for a paired t-test,
the investigators incorporated the following parameters:
power of 0.80, effect size estimate of 0.60 (medium
effect size)[59], probability of making a type II error
(beta) of 0.20, probability of making a type I error
(alpha) of 0.05. As previous research in this area was
not available at the time of our study, a medium effect
size was chosen based on our consensus of clinically
meaningful differences, considering the inclusion criteria
of an 80% decrease in self-reported pain intensity post-




Table 1 presents the baseline characteristics for the
WAD and normative comparison groups. The two
groups did not differ significantly with respect to age (p
= 0.94) and gender (15 females and 3 males in each
group). Fifty percent of the patients with chronic WAD
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injuries at the time of the study. Eighteen subjects that
initially underwent diagnostic intra-articular facet joint
injections went on to receive the diagnostic MBB proce-
dure. Subsequently, all 18 subjects were examined at all
measurement time-points in the study as all of them
experienced at least 80 percent relief in familiar neck
pain intensity following the MBB. Thus, there were no
exclusions from the post-MBB QST testing.
The reliability analyses performed on all pairs of
body parts for the CPT’sa n dP P T ’s, pre-and post-
MBB, in the WAD and normative comparison groups
revealed ICC’s (2,3) ranging from 0.977 to 0.994 (95%
CI: 0.955 - 0.997) [61]. The standard error of mea-
surement (SEM) associated with the QST protocol
ranged from 0.49 to 0.60 for CPT and 8 to 20 for
PPT. Considering the excellent agreement between left
and right side CPT and PPT data, the mean left and
r i g h ts i d ed a t aw e r ea v e r a g e da n dap o i n te s t i m a t e
representative of each body region was used for
further analyses [61].
WAD versus Normative Comparison Group at Baseline
The mean CPT and PPT data, for the cervical spine,
median nerve, and tibialis anterior test sites in the nor-
mative comparison and WAD groups, are summarized
in Table 2.
Cold Pain Thresholds
An independent samples t-test revealed significant dif-
ferences in CPT’s at the cervical spine between the
WAD and normative comparison groups (p < 0.001) at
baseline, with the WAD group having significantly
reduced CPT’s (Fig. 1).
Pressure Pain Thresholds
An independent samples t-test revealed significant dif-
ferences in PPT’s at all sites between the WAD and nor-
mative comparison groups (p < 0.001) at baseline, with
the WAD group having significantly lower PPT’s( F i g .
2).
WAD pre-MBB versus WAD post-MBB
Cold Pain Thresholds
A paired samples t-test revealed significant differences
in cervical spine CPT’s in the WAD group from baseline
to post-MBB (p < 0.001), with this group demonstrating
a significant decrease in CPT’s post-MBB (Fig. 1).
Pressure Pain Thresholds
A paired samples t-test revealed significant differences
in the PPT’s in the WAD group at all sites from base-
line to post-MBB (p < 0.05), with this group demon-
strating significant increases in PPT’s post-MBB (Fig. 2).
WAD post-MBB versus Normative Comparison Group
Cold Pain Thresholds
An independent samples t-test revealed significant dif-
ferences in CPT’s at the cervical spine between the
WAD post-MBB and normative comparison groups (p =
0.004), with the WAD post-MBB group having signifi-
cantly reduced CPT’s.
Pressure Pain Thresholds
An independent samples t-test revealed significant dif-
ferences in PPT’s at all sites between the WAD post-
MBB and normative comparison groups (p < 0.001),
with the WAD post-MBB group having significantly
lower PPT’s.
Discussion
The patients with chronic WAD in this study demon-
strated evidence of sensory hypersensitivity reflected by
reduced pain thresholds to cold temperature and pres-
sure stimulation in the cervical spine as well as reduced
pressure pain thresholds at distant sites over the periph-
eral trunk of the median nerve at the elbow and over
the tibialis anterior. These findings are similar to those
found in other studies investigating sensory hypersensi-
tivity in patients with chronic WAD [33,57,62]. Evidence
of altered pain thresholds to stimuli at distant regions











Duration of symptoms (mos ± SDŧ)
WAD (18) 83/17 45 (8) 6 (1) 44 (13) 27 (16)
Comparison (18) 83/17 45 (8) –– –
Groups did not differ in age (p = 0.94) and gender
§ NPRS - Numeric Pain Rating Scale
* NDI - Neck Disability Index
∓ SD - Standard deviation
Table 2 Mean (95% CI) CPT’s and PPT’s for WAD and
Normative Comparison Groups
WAD pre-MBB WAD post-MBB Control
CPT Cervical
(95% CI)
9.6 (5.7-13.5) 3.5 (1.2-5.9) 0.12 (0-0.3)
PPT Cervical
(95% CI)
165 (124-206) 232 (184-281) 348 (301-395)
PPT Median Nerve
(95% CI)
217 (174-258) 245 (195-295) 371 (343-400)
PPT Tib Ant
(95% CI)
350 (288-412) 381 (310-452) 569 (528-608)
CPT = Cold Pain Threshold (degrees Celsius)
PPT = Pressure Pain Threshold (kPa)
Tib Ant = Tibialis Anterior
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been attributed to altered central pain processing
[30,31,33,34,63].
Following anaesthetic blockade of the cervical zygapo-
physeal joint, and a subsequent significant decrease in
self-reported cervical spine pain intensity, the patients
with chronic WAD demonstrated significant changes in
measures indicative of sensory hypersensitivity. Specifi-
cally, the WAD group revealed a decrease in CPT’sa n d
an increase in PPT’s in the cervical spine and, impor-
tantly, an increase in PPT’s at the distal sites examined.
To our knowledge, this is the first study to reveal such
findings in patients with chronic WAD. These findings
suggest that sensory hypersensitivity may be modulated
by minimizing a potential peripheral source of pain, the
zygapophyseal joint, in patients with chronic WAD. The
prompt increase in local PPT’s and decrease in unilat-
eral CPT’s (measured over the anaesthetized zygapophy-
seal joint) noted in the WAD group post-MBB may
have been the result of reduced peripheral sensitization
via a reduction in receptive fields and/or deactivation of
glial cells, thus mitigating primary hyperalgesia in the
injured area [32,64,65]. Subsequently, the prompt
increase in distal PPT’s and decrease in bilateral CPT’s
in the WAD group post-MBB reflects alterations to cen-
tral nervous system hyperexcitability. Although not
thought of to respond rapidly, the reduction in central
hyperexcitability may have been due to inhibition of
COX-2 within the central nervous system [42,66].
Animal experimentation has provided evidence for the
mediatory effects of COX-2 inhibition on excitatory
mechanisms within the central nervous system [67].
Recently, it has been shown that myofascial trigger
points in the upper fibres trapezius of patients with
c h r o n i cW A Dm a yb eap e r i p h e r a ls o u r c em o d u l a t i n g
central hyperexcitability as evidenced by a decrease in
widespread mechanical hyperalgesia (pressure pain
thresholds) following local anaesthetic injections [45].
Of interest, cold hyperalgesia was not measured in this
study. As the presence of sensory hypersensitivity, pre-
dominantly cold hyperalgesia, has been associated with a
poor prognosis in patients with chronic WAD, it would
have been valuable to see the modulatory effects of the
myofascial trigger points on both widespread mechanical
hyperalgesia and cold hyperalgesia [3,68]. On the con-
trary, previous research failed to show changes in mea-
sures indicative of central hyperexcitability following
injection of local anaesthesia into painful and tender
points in patients with WAD [30]. The authors con-
cluded other anatomical sources in the cervical spine
might have upheld central hyperexcitability. Central
hyperexcitability may provide an explanation for the
generalized sensory hypersensitivity seen in some
patients with chronic WAD [32,33,35]. In our study, it
is plausible that the significant decrease in pain intensity
reported by the patients with chronic WAD post-MBB
resulted in decreased nociceptive input into the central
nervous system with subsequent decreased excitability
Figure 1 Mean (standard error) cold pain thresholds in the WAD and normative comparison groups.
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inhibitory pathways [35,38].
There are limitations of our study that warrant further
discussion. Although the WAD group demonstrated sig-
nificant changes in the measures of sensory hypersensi-
tivity in the post-MBB follow-up period, conclusions
cannot be made about long-term outcomes based on
the study design. Without comparison to a placebo
group, one cannot conclude that the outcomes of our
study were specific to the facet joint block procedure or
as a result of repeated testing. Although, our study
hypothesis focused on outcomes related to measures of
sensory hypersensitivity following a marked decrease in
cervical spine pain intensity, a potential peripheral pain
mechanism, not the efficacy of the facet joint block pro-
cedure itself.
Based on the typical duration of the anaesthetic, 2%
Lidocaine (2 hours), used for the MBB procedure in our
study, we assume that the measures of sensory hyper-
sensitivity eventually returned to baseline in the subjects
with chronic WAD. We cannot discuss this with abso-
lute certainty as the post-MBB measurement period was
complete within one hour of the MBB procedure and
no further follow-up was performed. Post-MBB, though
the WAD group improved with respect to measures of
sensory hypersensitivity, t h eW A Dg r o u pr e m a i n e ds t a -
tistically different from the normative comparison
group. This suggests that the WAD group was still sen-
sitized, to a certain extent, with respect to pressure pain
and cold pain thresholds, in comparison to healthy indi-
viduals. Our results propose that minimizing pain inten-
sity from a peripheral source of nociception may
modulate sensory hypersensitivity, but may not amend
central hyperexcitability to normative levels. This is
most likely the result of the complex interaction
between peripheral, spinal, and supraspinal mechanisms
involved in central hyperexcitability [32,39,69].
In consideration of the diagnostic zygapophyseal joint
blockade procedures used in our study one cannot rule
o u taf a l s ep o s i t i v er e s p o n s ew i t ha b s o l u t ec e r t a i n t y .
Figure 2 Mean (standard error) pressure pain thresholds in the WAD and normative comparison groups. The abbreviations for the
figures are as follows: MBB - medial branch block, WAD - whiplash associated disorder, SEM - standard error of the mean.
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cated to guard against such responses [54]. This involves
the administration of two different local anaesthetics on
different occasions. The patient should, ideally, note
pain relief that coincides with the duration of the anaes-
thetic used. In our study, as described in the methods
section, two diagnostic injection procedures were used.
The first diagnostic procedure involved an intra-articular
zygapophyseal joint injection while the second diagnos-
tic procedure involved a medial branch block. This com-
bination of diagnostic techniques possesses a similar
construct to comparative MBB’s and, to our knowledge,
has not been refuted in the scientific literature. For both
of our diagnostic procedures, target specificity was
determined by the use of a contrast medium to ensure
needle location [55]. In the case of the intra-articular
zygapophyseal joint injections, there were no incidences
of a radiate spread of contrast medium; indicative of a
lack of target specificity with failure to isolate the zyga-
pophyseal joint [55]. Furthermore, all patients in our
study reported an 80% or greater decrease in pain inten-
sity after both diagnostic injection procedures without
prior knowledge of expected outcomes leading us to
believe that they were legitimate in their responses. The
patients were not aware of our hypothesis with respect
to changes in measures indicative of sensory hypersensi-
tivity. As the outcomes of our study revealed changes in
sensory hypersensitivity following a significant decrease
in self-reported pain intensity in the cervical spine, one
may speculate that our diagnostic injection procedures
targeted a primary source of pain.
Although our study incorporated standardized mea-
sures of sensory hypersensitivity that have been detailed
in published research [33,36,49], they are subjective in
nature. The use of objective measures of sensory hyper-
sensitivity, such as the nociceptive withdrawal reflex
[31], and the inclusion of psychological factors in the
analysis of outcomes may provide more inclusive evi-
dence in research involving patients with chronicWAD
[70,71]. In our study, one examiner that was not blinded
to the study hypothesis performed the QST procedures.
Although observation bias [60] may be introduced with
such procedures, the QST protocol was standardized
and the individuals being examined had control of when
to cease each trial, thus minimizing the potential of bias
in our evaluation.
Based on the exploratory nature of our study, a cause
and effect relationship cannot be ascertained, but our
data illustrates that sensory hypersensitivity may be
modulated in the short-term. As the study sample
included a specific subset of the chronic WAD popula-
tion, the results of the study may not necessarily be
generalizable to all patients with chronic WAD. Future
studies including the measurement of cold pain
thresholds at distal sites may provide additional valuable
information in the context of underlying pain mechan-
isms in patients with chronic WAD. Further research,
incorporating longitudinal designs, examining the effects
of interventions aimed at minimizing the primary
source of cervical spine pain in patients with chronic
WAD on measures of sensory hypersensitivity, as well
as other clinical and functional outcome measures, is
warranted.
Conclusion
Our exploratory trial reveals a change in measures indi-
cative of sensory hypersensitivity in patients with
chronic WAD following a medial branch block proce-
dure in the cervical spine. This suggests that sensory
hypersensitivity may be modulated in the short-term
when a primary source of pain is reduced. Large clinical
trials involving long-term follow-up of interventions
aimed at reducing or eliminating the primary source of
cervical spine pain in patients with chronic WAD are
necessary.
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